Aigen Investment Management’s Gilead Sciences GILD Stock Holding History

Aigen Investment Management’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.79M	Buy	29,983 +11,489	+62%	+$1.51M	1.04%	7
2026 Q1	$2.58M	Buy	+18,494	New	+$2.59M	0.66%	32
2025 Q2	–	Sell	-12,098	Closed	-$1.36M	–	896
2025 Q1	$1.36M	Buy	+12,098	New	+$1.25M	0.22%	137
2024 Q2	–	Sell	-22,978	Closed	-$1.68M	–	867
2024 Q1	$1.68M	Buy	+22,978	New	+$1.77M	0.37%	67
2023 Q4	–	Sell	-10,022	Closed	-$751K	–	896
2023 Q3	$751K	Buy	+10,022	New	+$771K	0.14%	236
2022 Q4	–	Sell	-13,547	Closed	-$836K	–	631
2022 Q3	$836K	Buy	+13,547	New	+$854K	0.12%	218
2022 Q1	–	Sell	-144,057	Closed	-$10.3M	–	743
2021 Q4	$10.3M	Buy	+144,057	New	+$9.92M	0.63%	18

Other funds holding GILD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Aigen Investment Management's GILD Position: Q2 2026 in Review

Aigen Investment Management increased its Gilead Sciences (GILD) stake by 62% in Q2 2026, buying an estimated $1.51M and bringing the position to 29,983 shares worth $3.79M. The position accounts for 1.04% of the portfolio, ranked #7.

Aigen Investment Management first reported a position in GILD in Q4 2021 and has held it in 7 quarters since. The position peaked at $10.3M in Q4 2021. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

Aigen Investment Management held 29,983 shares of Gilead Sciences worth $3.79M as of Q2 2026.
Aigen Investment Management bought 11,489 Gilead Sciences shares in Q2 2026, an estimated $1.51M.
Gilead Sciences made up 1.04% of Aigen Investment Management's portfolio in Q2 2026, its #7 holding.
Aigen Investment Management first reported a position in Gilead Sciences in Q4 2021 and has held it in 7 quarters since.
Aigen Investment Management's Gilead Sciences position peaked at $10.3M in Q4 2021.
2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Aigen Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.